Joshua K. Rim
Jessica L. Zwerling
<p style="font-family: Arial; font-size: 11.0pt;"> </p>
<p style="font-family: Arial; font-size: 11.0pt;"><span style="font-family: 'Times New Roman'; font-size: medium;">Jessica Zwerling, MD, MS, has a clinical focus on identifying risk factors for cognitive decline and dementia, as well as factors that promote successful aging. Zwerling’s research focuses on optimizing healthcare delivery systems. Her work has been published in many peer-reviewed journals and has been shared at national and international invited conferences. She has developed the clinical and didactic programs used to enhance health professionals’ capacity to screen, diagnose, and develop personalized plans of care for patients with Alzheimer disease and related dementias for the Montefiore Health System. She also is a nationally recognized expert in aging/ dementia and serves as an adviser on multiple panels related to recruitment in neurodegenerative disease clinical trials. In addition, she has pioneered the age-friendly initiatives at her health system and certified her Center of Excellence with the highest age-friendly recognition. Zwerling is board certified in neurology as well as the subspecialty of neuromuscular medicine by the American Board of Psychiatry and Neurology. She is a member of the American Geriatrics Society and the American Academy of Neurology. Additionally, she has been named “2020 Health Care Hero” by the Westchester magazine, and was named one of the New York Super Doctors in The New York Times from 2016 to 2023. She has also been appointed and completed the Physician Leaders Program at Montefiore Health System.</span></p>
<ul>
<li><strong>B.S. with Special Certification in Gerontology:</strong> Cornell University </li>
<li><strong>M.S.:</strong> Natural Science, University at Buffalo Medical School /Roswell Park Cancer Institute</li>
<li><strong>M.D. with Thesis Honors and Research Honors:</strong> University at Buffalo Medical School </li>
<li><strong> Internship</strong>: Albert Einstein/Beth Israel Medical CenterResidency</li>
<li><strong>Chief Residency</strong>: Albert Einstein/Montefiore Medical Center </li>
<li><strong>Fellowship:</strong> Neuromuscular disease/Neurophysiology</li>
<li><strong>Fellowship:</strong> Geriatric Neurology (3 years) Albert Einstein/Montefiore Medical Center; NIH recipient of T32</li>
<li><strong> Board Certification:</strong> American Board of Neurology and Psychiatry (Neurology)</li>
<li><strong> Neuromuscular Board Certified</strong>: American Academy of Neurology</li>
</ul>
<p>To meet the needs clinically of our patients/caregivers, I developed and published a new model of care for the community. This model is called the Coordinated Care At Risk/Remote Elderly Program (CCARRE) and focuses on the patient/caregiver dyad. Additional funding supported the expansion of a telehealth depression treatment program for older adults which supported recruitment in our diverse, frail population. Foundation support has provided the ability to provide culturally and language competent assessments/evaluations and management of neurodegenerative diseases and cognitive impairment. Other grant funding supports the implementation of the 5cs program (Comprehensive Culturally relevant Care for Cognitively impaired and their Caregivers – a pathway to equity in health care and model for systems transformation. Current funding for BRAID in conjunction will bridge our research aims and This grant uses the MHS-pioneered BRAID model (Bridging Research, Accurate Information, and Dialogue) where researchers/providers gain a deep understanding of the needs of our diverse and vulnerable population. To aid in clinical trial enrollment/retention, this work focuses on the Age Friendly 4Ms--What Matters, Medication, Mentation, and Mobility and strengthens the collaboration between the health system and the surrounding community.
</p></p>Educational models through research: Additional national funding supported the building of a network of skilled nursing facilities and expanded my role as a leader of a Covid Action Network through Project ECHO. I developed the curriculum for interprofessional and brought the community of 99 skilled nursing facilities together with our Montefiore Health System experts to provide evidence-based Covid 19 care. In addition - I obtained funding to implement the MOLST or eMOLST into our collaborative of skilled nursing facilities to assure safe care transitions and encourage the end-of-life directives to be completed electronically.</p>
My overall clinical research focuses on how to address the neurodegenerative disease. The pandemic has forced a reevaluation of resources and additional funding to support a robust educational network that provides interdisciplinary CME, as well as telehealth for the older adult, which was crucial. Building a patient-caregiver evaluation center through foundation and state/national funding is crucial and has created a niche as an expert in neurodegenerative disease with a focus on under resourced, frail populations. This group is crucial to identify and recruit for future trials and our site has been identified as a patient-centered outcome center.
<p>Jessica Zwerling, MD, MS, is Director, Montefiore Hudson Valley Center of Excellence for Alzheimer’s Disease; Program Director, UCNS Geriatric Neurology Fellowship; Director, Memory Disorders Center; and Associate Director, Center for the Aging Brain at Montefiore. She is also Associate Professor of Neurology, Assistant Professor of Psychiatry, Assistant Professor of Pediatrics and Clinical Director of the Einstein Aging Study at our Albert Einstein College of Medicine. Her clinical focus is on identifying risk factors for cognitive decline and dementia, as well as factors that promote successful aging.</p><p>In 1996, Dr. Zwerling received her Bachelor of Science in human development and family studies at Cornell University, as well as earned a concentration in Gerontology. She continued her education at Roswell Park Cancer Institute/University at Buffalo, focusing on the validation of dementia rating scales, receiving her Master of Science in 2000 and her Doctor of Medicine in 2001, She earned her Doctor of Medicine with both thesis and research honors. Her postgraduate training began with an internship at Beth Israel Medical Center, followed by a residency/chief residency at Montefiore Medical Center. In 2006, she completed a fellowship in neuromuscular disease, electromyography and neurophysiology at Montefiore. In 2012, she completed a three-year NIH research fellowship in aging at the Albert Einstein College of Medicine.</p><p>Dr. Zwerling’s research focuses on optimizing healthcare delivery systems and coined the term “culturally competent collaborative care of the cognitively impaired older adult”. Her work has been published in many peer-reviewed journals and has been shared at a number of national invited lectures. She has developed the clinical and didactic programs used to enhance health professionals’ capacity to screen, diagnose and develop personalized plans of care for patients with Alzheimer’s and related dementias for the Montefiore Health System.</p><p>Dr. Zwerling has received multiple grants from the Leslie R. Samuels and Fan Fox Foundation for work in memory and gait. This has created postdoctoral programs for trainees in the field of neuropsychology, social work, as well as geriatric neurology. In 2017 and 2019, Dr. Zwerling received the Research Recognition Award in Alzheimer’s Disease at the CaringKind Forget-Me-Not Gala. She was also named one of the New York Super Doctors in The New York Times from 2016 to 2020. Dr. Zwerling is board certified in neurology as well as the subspecialty of neuromuscular medicine by the American Board of Psychiatry and Neurology. She is a member of the American Geriatrics Society and the American Academy of Neurology. Additionally, she has been named “2020 Health Care Hero” by the Westchester magazine.</p>
Eathar Saad
<p>Rehabilitation Medicine, Electrodiagnosis, Rheumatology.</p>
General Physiatry, Electrodiagnosis, Spinal Cord Injury Medicine, Stroke Rehabilitation, Musculoskeletal conditions like back pain, neck pain , shoulder pain, elbow pain.
Mooyeon Oh-Park
<p>Dr. Mooyeon Oh-Park, M.D., graduated from the Seoul National University College of Medicine. With a background in rehabilitation medicine, she wants to contribute to keeping the aging population active as a priority in healthcare. Her purpose in Rehabilitation research is to identify the older individuals early in the process of disablement, and to develop mechanism based interventions for mobility difficulty. As a member of Division of Cognitive and Motor Aging, her research involves quantitative measure of gait and balance using instrumented carpet and Swaystar inclinometer. Her eventual goal is early detection of mobility decline and dissemination of interventions for prevention of mobility decline.</p>
The clinical area of interest of Dr. Mooyeon Oh-Park includes geriatric rehabilitation from the care of master athletes to older adults with disability, electrodiagnosis, and sports medicine. The clinical area of interest of Dr. Mooyeon Oh-Park includes geriatric rehabilitation from the care of master athletes to older adults with disability, electrodiagnosis, and sports medicine.<quillbot-extension-portal></quillbot-extension-portal>
Research interest includes prevention and intervention of delirium, frailty, technology and innovation in healthcare, and preservation of mobility and function of older adults in the community. She also has expertise in healthcare management, population health, and creating value-based care.<quillbot-extension-portal></quillbot-extension-portal><quillbot-extension-portal></quillbot-extension-portal>
<p>Mooyeon Oh-Park, MD, MS, is Chief Medical Officer, Senior Vice President, Burke Rehabilitation Hospital, Professor, Rehabilitation Medicine and Professor, Neurology at Montefiore Einstein. Her clinical focus centers on geriatric rehabilitation from the care of master athletes to older adults with disability, electrodiagnosis and sports medicine.</p><p>After earning her Doctor of Medicine at Seoul National University College of Medicine in Seoul, South Korea, in 1989, Dr. Oh-Park completed a rotational internship in 1990 and a physical medicine and rehabilitation residency in 1991 at Seoul National University Hospital. She then came to Memorial Sloan-Kettering Cancer Center to complete a postdoctoral research fellowship in biochemical immunogenetics in 1993. Following this, Dr. Oh-Park completed an internal medicine internship at Our Lady of Mercy Medical Center in 1994 before completing an additional physical medicine and rehabilitation residency at Montefiore in 1997. In 2009, Dr. Oh-Park earned her Master of Science at Einstein. She will graduate with her Master in Health Care Management from Harvard T.H. Chan School of Public Health in 2023.</p><p>Dr. Oh-Park’s research interests include the prevention and intervention of delirium and frailty, technology and innovation in healthcare, and preservation of mobility and function of older adults in the community. She also has expertise in healthcare management, population health and creating value-based care. Dr. Oh-Park has been principal investigator, site principal investigator and co-investigator on a number of funded research projects. Her work has been published in numerous peer-reviewed journals and other scientific publications and she has given national and international presentations. She is also the Editor-in-Chief for the Current Report on Physical Medicine and Rehabilitation, a reviewer for journals such as the <em>American Journal of Physical Medicine and Rehabilitation</em> and <em>Gait and Posture</em>, and she sits on the editorial boards of several prestigious journals, such as the <em>American Journal of Physical Medicine & Rehabilitation, Annals of Rehabilitation Medicine</em> and <em>Annals of Geriatric Research & Medicine</em>.</p><p>Dr. Oh-Park is board certified in Physical Medicine and Rehabilitation, Electrodiagnostic Medicine, Sports Medicine and Neuromuscular Medicine. She is also certified by the American Registry for Diagnostic Medical Sonography (ARDMS). Dr. Oh-Park has won many awards for her work, including Best Mentor of the Year from Burke Rehabilitation Hospital in 2019, Doctor of Distinction, Exceptional Leadership Category from Westchester Business Council in 2020, Notable Women in Healthcare by Crain's New York Business in 2018, 2019 and 2021, and Outstanding Service Award from the Association of Academic Physiatrists in 2023.</p>
Fabreena E. Napier
<p>Interest is in clinical neurology and electromygraphy.</p>
Mark J. Milstein
Dr. Milstein focuses on inpatient neurological consultation and outpatient neuromuscular evaluation with a special focus on myasthenia gravis.
Dr. Milstein’s research is focused on medical education, unique neurological presentations, and neuromuscular conditions, including myasthenia gravis and Guillain-Barré Syndrome.
<p>Mark J. Milstein, MD, FAAN, is Director of the Adult Neurology Residency Training Program at Montefiore and Associate Professor of Neurology and Medicine at Albert Einstein College of Medicine. His clinical work focuses primarily on neurohospitalist and neuromuscular medicine / electromyography (EMG), as well as general neurology.</p><p>After earning a degree in Biology at the University of Pennsylvania in 1997, Dr. Milstein attended Albert Einstein College of Medicine, where he received his Doctor of Medicine in 2001. Dr. Milstein completed five years of postgraduate training at Montefiore from 2001-2006, including his internship in medicine, residency in neurology and fellowship in clinical neurophysiology. Dr. Milstein was Chief Resident in the final year of his neurology training.</p><p>Dr. Milstein’s research focuses on medical education, inpatient neurology and neuromuscular medicine. His work has been published in a number of peer-reviewed journals, and includes original research, review articles, and books. Dr. Milstein has been an invited speaker at a number of national lectures and presentations.</p><p>At the 15th Annual Doctors Recognition Day in 2018, Dr. Milstein received the Peer to Peer Excellence in Medicine Award from the Bronx County Medical Society. He is a member of numerous professional societies, including the American Medical Association (AMA), the American Academy of Neurology (AAN) and the New York State Neurological Society. He holds leadership positions in the AAN and the New York County Medical Society (NYCMS).</p><p>Dr. Milstein is board certified by the American Board of Psychiatry and Neurology.</p>
Steven Herskovitz
<p>Dr. Herskovitz is Professor of Clinical Neurology and Director of the EMG Lab / Neuromuscular division. He earned his medical degree from Cornell University Medical Center in 1980. He completed residencies in both Internal Medicine and Neurology, followed by a Fellowship in Electromyography/Neuromuscular Disorders, all at the Albert Einstein College of Medicine. He is a diplomate of the ABIM, ABPN, ABEM, and ABPN-AQNM. His clinical research interests include the peripheral neuropathies, entrapment neuropathies and peripheral neurotoxicology. He has published on various aspects of carpal tunnel syndrome including electrophysiologic diagnosis, treatment and autonomic features, clinical features of a variety of peripheral neuropathies, and the neurotoxicology of pharmaceutical and industrial agents. He is author of: <em>Herskovitz S, Scelsa S, Schaumburg HH. Peripheral Neuropathies in Clinical Practice. Contemporary Neurology Series. Oxford University Press. New York. 2010</em>. Two positions are available yearly in the clinical neurophysiology /EMG fellowship program.</p>
Dr. Herskovitz focuses on the clinical and neurodiagnostic (EMG; neuromuscular ultrasound) evaluation of neuromuscular disorders.
Dr. Herskovitz's research is focused on the clinical and neurodiagnostic assessment of neuropathies.
<p><strong>Bibliography</strong><br /><br /><strong>A. Original Communications in Reviewed Journals:</strong></p>
<p>1. Lipton RB, Krupp L, Horoupian D, Herskovitz S, Arezzo JC, Kurtzberg D. Progressive multifocal leukoencephalopathy of the posterior fossa in an AIDS patient: Clinical, radiographic and evoked potential findings. European Neurology. 28:258?261,1988.</p>
<p>2. Herskovitz S, Lipton RB, Lantos G. NeuroBehcet's disease: CT and clinical correlates. Neurology. 38:1714?1720, 1988.</p>
<p>3. Herskovitz S, Siegel SE, Schneider AT, Nelson SJ, Goodrich JT, Lantos G. Spinal cord toxoplasmosis in AIDS. Neurology. 39:1552?1553, 1989.</p>
<p>4. Loh F, Herskovitz S, Berger AR, Swerdlow M. Brachial plexopathy associated with interleukin 2 therapy. Neurology. 42:462?463, 1992.</p>
<p>5. Newman LC, Herskovitz S, Lipton RB, Solomon S. Chronic paroxysmal headache: Two cases with cerebrovascular disease. Headache 32: 75?76, 1992.</p>
<p>6. Gonzales GR, Herskovitz S, Rosenblum M, et al. Dejerine Roussy syndrome caused by CNS toxoplasmosis in patients with AIDS. Neurology 42: 1107?1109, 1992.</p>
<p>7. Herskovitz S, Gordon M, Strauch B. Shiatsu massage induced injury of the median recurrent motor branch. Muscle & Nerve 15 (10): 1215, 1992.</p>
<p>8. Herskovitz S, Loh F, Berger AR, Kucherov M. Erythromelalgia: Association with hereditary sensory neuropathy and response to amitriptyline. Neurology 43: 621?622, 1993.</p>
<p>9. Herskovitz S, Bieri P, Berger AR. Depressor septi nasi myokymia. Muscle & Nerve 17: 116, 1994.</p>
<p>10. Strominger MB, Slamovits TL, Herskovitz S, Lipton RB. Transient worsening of optic neuropathy as a sequela of the Jarisch?Herxheimer reaction in the treatment of Lyme disease. J Neuro Ophthalmol 14(2): 77?80, 1994.</p>
<p>11. Scelsa SN,, Lipton RB, Sanders H, Herskovitz S. Headache characteristics in hospitalized patients with Lyme disease. Headache 35 (3): 125-130, 1995.</p>
<p>12. Berger AR, Herskovitz S, Kaplan J. Late motor involvement in cases presenting as chronic sensory demyelinating polyneuropathy. Muscle & Nerve 18: 440-444, 1995.</p>
<p>13. Herskovitz S, Berger AR, Lipton, RB. Low dose, short-term oral prednisone in the treatment of carpal tunnel syndrome. Neurology 45: 1923-1925, 1995.</p>
<p>14. Berger AR, Herskovitz, S, Scelsa SN. Restoration of IVIg efficacy by plasma exchange in CIDP. Neurology 45: 1628-1629, 1995.</p>
<p>15. Oware A, Herskovitz S, Berger AR. Long thoracic nerve palsy associated with chiropractic manipulation. Neurology 18:1351, 1995.</p>
<p>16. Berger AR, Swerdlow M, Herskovitz S. Myasthenia gravis presenting with uncontrollable flatulence and urinary/fecal incontinence. Muscle & Nerve 19: 113-114, 1996.</p>
<p>17. Scelsa SN, Berger AR, Herskovitz S. The diagnostic utility of F waves in L5/S1 radiculopathy. Muscle & Nerve 18: 1496, 1995.</p>
<p>18. Scelsa SN, Herskovitz S, Berger AR. A predominantly motor polyradiculopathy of Lyme disease. Muscle & Nerve 19: 780-783, 1996.</p>
<p>19. Scelsa SN, Herskovitz S, Bieri P, Berger AR. Median mixed and sensory conduction studies in carpal tunnel syndrome. Electroencephalography and Clinical Neurophysiology 109: 268-273, 1998</p>
<p>20. Scelsa SN, Herskovitz S, Reichler B. Treatment of Mononeuropathy Multiplex in Hepatitis C Virus and Cryoglobulinemia. Muscle & Nerve 21: 1526-1529, 1998.</p>
<p>21. Scelsa SN, Herskovitz S. Miller Fisher syndrome: axonal, demyelinating or both? Electromyogr. Clin. Neurophysiol. 40: 497-502, 2000.</p>
<p>22. Manfredi PL, Herskovitz S, Folli F, Pigazzi A, Swerdlow ML. Spinal epidural abscess: treatment options. Eur Neurol 40:58-60, 1998.</p>
<p>23. Berger AR, Schaumburg HH, Freeman K, Gourevitch MN, Herskovitz S, Arezzo JC. Prevalence of peripheral neuropathy in injection drug users. Neurology 1999; 53: 592-597</p>
<p>24. Verghese J, Galanopoulou AS, Herskovitz S. Autonomic dysfunction in idiopathic carpal tunnel syndrome. Muscle & Nerve 23: 1209-1213, 2000.</p>
<p>25. Scelsa S, Berger A, Herskovitz S. Electrophysiologic correlates of L5/S1 radiculopathy. Electromyogr. clin. Neurophysiol 2001, 41, 145-151.</p>
<p>26. Verghese J, Bieri PL, Gellido C, Schaumburg HH, Herskovitz S. Peripheral neuropathy in young-old and old-old patients. Muscle & Nerve 24: 1476-1481, 2001.</p>
<p>27. Scelsa S, Ghali V, Herskovitz S, et al. Blood ãä T cells, Campylobacter jejuni, and GM1 titers in Guillain Barre syndrome. Muscle & Nerve 30: 423-432, 2004.</p>
<p>28. Geyer H, Schaumburg HH, Herskovitz S. Methyl bromide intoxication causes reversible, symmetric, brainstem and cerebellar MRI lesions. Neurology 2005; 64:1279-1281.</p>
<p>29. Herskovitz S, Song H, Cozien D, Scelsa S. Sensory symptoms in acquired neuromyotonia. Neurology 2005;65:1330-1331.</p>
<p>30. Schaumburg HH, Herskovitz S, Cassano V. Occupational manganese neurotoxicity provoked by hepatitis C. Neurology 2006;67:322-3.</p>
<p>31. Blumenthal S, Herskovitz S, Verghese J. Carpal tunnel syndrome in older adults. Muscle & Nerve 2006;34:78-83.</p>
<p>32. Schaumburg HH, Herskovitz S. Is acquired copper deficiency myeloneuropathy from denture cream use a clue to clioquinol-induced subacute myelo-optic neuropathy (SMON)? Neurology 2008; 71 (9):622.</p>
<p>33. Robbins MS, Roth S, Swerdlow ML, Bieri P, Herskovitz S. Optic neuritis and palatal dysarthria as presenting features of post-infectious GQ1b antibody syndrome. Clin Neurol Neurosurg 2009;111:465-466.</p>
<p>34. Issa SS, Herskovitz S, Lipton RB. Acquired neuromyotonia as a paraneoplastic manifestation of ovarian cancer. Neurology 2011;76:101-103 .</p>
<p><strong>B. Books, Chapters in Books, Editorials and Review Articles:</strong></p>
<p>1. Contributing author: Pousada, L, Osborn HH. Emergency Medicine for the House Officer. Williams and Wilkins, 1986. (chapters on headache and CPR).</p>
<p>2. Contributing author: Schaumburg HH, Berger AR, Thomas PK. Disorders of Peripheral Nerves, 2nd edition, F.A. Davis, 1992.</p>
<p>3. Berger AR, Herskovitz S. Cumulative trauma disorders and occupational nerve disease. In: Rosenberg, N ed. Occupational and Environmental Neurology. Butterworth-Heinemann, Boston, 1995.</p>
<p>4. Assistant Editor: Spencer PS, Schaumburg HH, Ludolph AC. Experimental and Clinical Neurotoxicology, 2nd edition. Oxford University Press, 2000.</p>
<p>5. Schaumburg HH, Herskovitz S. The Weak Child – A Cautionary Tale. N Engl J Med 2000 (editorial); 342, 127-129.</p>
<p>6. Herskovitz, S. Toxic neuropathies – Amiodarone, Gold, Perhexilene, Misonidazole. In Medlink Neurology (www.medlink.com), 2001/2002/2003/2004/2005/2006.</p>
<p>7. Herskovitz S, Schaumburg HH. Neuropathy due to drugs. In: Dyck PJ, Thomas PK, editors: Peripheral Neuropathy, 4th edition, 2005.</p>
<p>8. Herskovitz S, Scelsa S, Schaumburg HH. Peripheral Neuropathies in Clinical Practice. Contemporary Neurology Series. Oxford University Press. New York. 2010.</p>
<p>Steven Herskovitz, MD, is Director, Neuromuscular Medicine and Director, Electromyography (EMG) Lab at Montefiore. He is also Professor of Neurology at our Albert Einstein College of Medicine. Dr. Herskovitz’s clinical focus is on the evaluation and management of all neuromuscular disorders, with a particular interest in electrodiagnostic and neuromuscular ultrasound assessment.</p><p>In 1976, Dr. Herskovitz received his Bachelor of Science in biology at the State University of New York at Stony Brook. He then attended Cornell University Medical College, where he received his Doctor of Medicine in 1980. From 1980 to 1987, Dr. Herskovitz completed his postgraduate training at Montefiore. During this time, he spent his first year as a medical intern and next two years as a medical resident. In 1983, he began a three-year neurology residency, becoming Chief Resident in the final year. He ended his postgraduate training with a fellowship in Electromyography and Neuromuscular Diseases.</p><p>Expanding on his clinical focus, Dr. Herskovitz’s research centers on clinical, electrodiagnostic and neuromuscular ultrasound assessment of neuropathies. His work has been published in many peer-reviewed journals, books, review articles and abstracts.</p><p>Dr. Herskovitz is board certified by the American Board of Internal Medicine, the American Board of Psychiatry and Neurology, including Added Qualification in Neuromuscular Medicine, and the American Board of Electrodiagnostic Medicine. He is a member of the American Academy of Neurology and the American Association of Neuromuscular and Electrodiagnostic Medicine.</p>
Leslie D. Delfiner
Phyllis L. Bieri
<p>Dr. Phyllis Bieri sees patients in the EMG Laboratory of the Department of Neurology at Montefiore Medical Center. Her area of interest is the diagnososis and treatment of neuromuscular diseases, including diseases of nerve, muscle, neuromuscular junction and anterior horn cell. She participates in the training of EMG and EEG fellows, and has particular expertise in performing electromyography and nerve conduction studies.</p>
<p class="MsoNormal">Scelsa, S.N., Ghali, V., Herskovitz, S., <strong>Bieri, P.L.</strong>, Shank, D.L., MacGowan, D.D.J., and Liau, S., “Blood gd T Cells, <em>Campylobacter jejuni</em>, and GM1 Titers in Guillain-Barré Syndrome,” <em>Muscle & Nerve,</em> <strong>30</strong>:423-432,2004.</p>
<p class="MsoNormal"> </p>
<p class="MsoNormal">Verghese, J., <strong>Bieri, P.L.</strong>, Gellido, C., Schaumburg, H.H., and Herskovitz, S., “Peripheral Neuropathy in Young-old and Old-old Patients,” <em>Muscle & Nerve,</em> <strong>24</strong>:1476-1481, 2001.</p>
<p> </p>
<p><strong>Bieri, P.L., “</strong>Botulism,” Spencer, Schaumburg, Ludolph eds., <em>Experimental and Clinical Neurotoxicology</em>, 2<sup>nd</sup> edition. Oxford University Press, 2000.</p>
<p class="MsoNormal"> </p>
<p class="MsoNormal">Scelsa, S.N., Herskovitz, S., <strong>Bieri, P.L.,</strong> and Berger, A.R., “Median Mixed and Sensory Nerve Conduction Studies in Carpal Tunnel Syndrome,” <em>Electroencephalography and Clinical Neurophysiology,</em> <strong>109</strong>:268-273 (1998).</p>
<p class="MsoNormal"> </p>
<p class="MsoNormal"><strong>Bieri, P.L.,</strong> Arezzo, J.C., and Weinstein, D.E., “Abnormal Nerve Conduction Studies in Mice Expressing a Mutant Form of the POU Transcription Factor SCIP,” <em>Journal of Neuroscience Research</em>, <strong>50</strong>:821-828, (1997).</p>
<p class="MsoNormal"> </p>
<p class="MsoNormal">Maycox, P.R., Ortuño, D., Burrola, P., Kuhn, R., <strong>Bieri, P.L.,</strong> Arezzo, J.C., and Lemke, G., “A Transgenic Mouse Model for Human Hereditary Neuropathy with Liability to Pressure Palsies,” <em>Molecular and Cellular Neuroscience</em>, <strong>8</strong>, 405-416 (1997).</p>
<p class="MsoNormal"> </p>
<p class="MsoNormal">Liedtke, W., Edelmann, W., <strong>Bieri, P.L.,</strong> Chiu, F-C, Cowan, N.J., Kucherlapati, R., and Raine, C., “GFAP Is Necessary for the Integrity of CNS White Matter Architecture and Long-Term Maintenance of Myelination,” <em>Neuron</em>, <em>17</em>, 607-715, 1996.</p>
<p class="MsoNormal"> </p>
<p class="MsoNormal">Chandross, K.J., Kessler, J.A., Cohen, R.I., Simburger, E., Spray, D.C., <strong>Bieri, P.</strong>, Dermietzel, R., “Altered Connexin Expression after Peripheral Nerve Injury,” <em>Molecular and Cellular Neuroscience,</em> <strong>7</strong>, 501-518, 1996.</p>
<p class="MsoNormal"> </p>
<p class="MsoNormal">Michaelson, M., <strong>Bieri, P</strong>., Mehler, M., Xu, H., Arezzo, J., Pollard, J., and</p>
<p class="MsoNormal">Kessler, J., “CSF-1 Deficiency in Mice Results in Abnormal Brain Development.” <em>Development</em>, <strong>122</strong>, 2661-2672, 1996.</p>
<p class="MsoNormal"> </p>
<p class="MsoNormal">Herskovitz, S., <strong>Bieri, P.,</strong> and Berger, A., "Depressor Septi Nasi Myokymia," <em>Muscle and Nerve</em>, Jan., 1994.</p>
<p class="MsoNormal"> </p>
<p>Phyllis Bieri, MD, is an attending physician at Montefiore Einstein and Assistant Professor, Neurology at our Albert Einstein College of Medicine. Dr. Bieri's clinical focus centers on the accurate diagnosis of neuromuscular disease through careful history, neurologic examination and electrodiagnostic tools such as electromyography (EMG), nerve conduction study (NCS) and neuromuscular ultrasound. She sees adults and pediatric patients referred to the EMG laboratory for consultation.</p><p>After obtaining her Bachelor of Science in chemistry and biology from Antioch College in 1982, Dr. Bieri earned her Doctor of Medicine at Ohio State University in 1988. She then attended Albert Einstein College of Medicine, completing an internal medicine internship in 1989 and her neurology residency in 1992, where she was Chief Resident in her final year. Following her final year of residency, Dr. Bieri completed an EMG/neuromuscular disease fellowship at the same institution.</p><p>Dr. Bieri's research is focused on diseases that present to the EMG laboratory, including hereditary and acquired peripheral neuropathies, disorders of the anterior horn cell, myopathies, muscular dystrophies and polyradiculopathies and entrapment neuropathies. Her work has been published in numerous peer-reviewed publications, book chapters and abstracts.</p><p>Dr. Bieri is board certified by the American Board of Psychiatry and Neurology in Neuromuscular Medicine and Neurology with added qualifications in Clinical Neurophysiology. She is also certified in Electromyography by the American Association of Neuromuscular and Electrodiagnostic Medicine. Dr. Bieri is a member of the American Academy of Neurology and the American Association of Neuromuscular and Electrodiagnostic Medicine. In 1989, she received the Leo M. Davidoff Award for excellence in teaching.</p>